Printer Friendly
The Free Library
14,529,797 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Amgen Announces Webcast of Third Quarter Financial Results.


THOUSAND OAKS Thousand Oaks, residential city (1990 pop. 104,352), Ventura co., S Calif., in a farm area; inc. 1964. Avocados, citrus, vegetables, strawberries, and nursery products are grown. , Calif. -- Amgen (Nasdaq:AMGN), the world's largest biotechnology company, today announced that it plans to report its third quarter financial results on Wednesday Wednesday: see week. , October 19, 2005 after the close of the financial markets. The announcement will be followed by a conference call with the investment community at 2 p.m. Pacific Daylight Time.

Participating in the call from Amgen will be Kevin Sharer, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the Internet Internet

Publicly accessible computer network connecting many smaller networks from around the world. It grew out of a U.S. Defense Department program called ARPANET (Advanced Research Projects Agency Network), established in 1969 with connections between computers at the
 and will be available to members of the news media, investors and the general public. The conference call, including the question and answer session, is expected to last approximately one hour.

The webcast of the conference, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's Web site, www.amgen.com, under Investors. Information regarding presentation times, webcast availability, and webcast links are noted on Amgen's Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 Events Calendar. The webcast will be archived and available for replay 72 hours after the event.

About Amgen

Amgen discovers, develops and delivers innovative human therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease Kidney Disease Definition

Kidney disease is a general term for any damage that reduces the functioning of the kidney. Kidney disease is also called renal disease.
, rheumatoid arthritis rheumatoid arthritis

Chronic, progressive autoimmune disease causing connective-tissue inflammation, mostly in synovial joints. It can occur at any age, is more common in women, and has an unpredictable course.
, and other serious illnesses. With a broad and deep pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 3, 2005
Words:294
Previous Article:EarthFirst Technologies Appoints Barry Markowitz to Board Of Directors.
Next Article:Covalon Significantly Increases Sales Orders for Fourth Quarter 2005.
Topics:



Related Articles
MEDICARE CUT HURTS AMGEN'S FOURTH-QUARTER, 1997 EARNINGS.(BUSINESS)(Statistical Data Included)
RULING MAY AID AMGEN EARNINGS.(Business)
AMGEN INCOME BEATS FORECAST.(BUSINESS)
AMGEN ANNOUNCES $1 BILLION BUYBACK.(BUSINESS)(Statistical Data Included)
Drug settlement.(Review & preview: August 22-28)(Amgen Inc. settles patent dispute with Genentech Inc.)(Brief Article)
RATING DIPS ON AMGEN STOCKS ANALYST CITES RIVAL'S EFFORTS.(Business)
Local companies hard pressed to keep up in profit department.(Wall Street West)
Company results mixed.(Technology Update)
Stock buyback, patent victory give bounce to Amgen shares.(Corporate Focus)
AMGEN PROFITS SOAR NEWER DRUGS FUEL SURGE.(Business)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles